ReviewCancer drug resistance (Alhambra, Calif.)2021

Targeting mTOR and eIF4E: a feasible scenario in ovarian cancer therapy.

Alice Romagnoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.